SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today
Emerging markets expert and founder of Mobius Capital Partners, Mark Mobius, is not piqued by the metaverse but thinks the companies that are creating it could be an interesting opportunity. He also had a lot to say on other topics such as cryptocurrency and recession.